Metraipolis › archive › dc_eab6fc6026bc

SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era — Europe PMC PMID:41303740

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41303740
DOI
10.3390/medicina61111903
License (as archived)
solo-consultazione
Archived
2026-11-09T02:35:42.824Z
SHA-256 of the archived text
75cdd9f503fcdf6effee2385aa989753c095d0ab55e097bc6a58938c680f0418
Stable URL of this page
https://metraipolis.com/documento/dc_eab6fc6026bc

How to cite

SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era — Europe PMC PMID:41303740 — Europe PMC (en), https://europepmc.org/article/MED/41303740 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab6fc6026bc (Metraipolis archive dc_eab6fc6026bc, sha256 75cdd9f503fcdf6effee2385aa989753c095d0ab55e097bc6a58938c680f0418)
BibTeX
@misc{dceab6fc6026bc,
  title = {SGLT2 Inhibitors in the Management of Cardio-Renal-Metabolic Syndrome: A New Therapeutic Era — Europe PMC PMID:41303740},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41303740},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab6fc6026bc; sha256 75cdd9f503fcdf6effee2385aa989753c095d0ab55e097bc6a58938c680f0418},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41303740. Agents can read the archived copy with the MCP tool read_document.